+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Epilepsy Market and Competitive Landscape - 2020

  • ID: 5023387
  • Report
  • April 2020
  • Region: Global
  • Fore Pharma
1 of 2
The research report Global Epilepsy Market and Competitive Landscape - 2020, provides comprehensive insights into the Epilepsy pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Epilepsy market size and drug sales. It also provides insights into Epilepsy epidemiology and late stage pipeline.

This research covers the following: Epilepsy treatment options, Epilepsy late stage clinical trials pipeline, Epilepsy prevalence by countries, Epilepsy market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).

Research Scope:
  • Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
  • Epilepsy pipeline: Find out drugs in clinical trials for the treatment of Epilepsy by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Epilepsy epidemiology: Find out the number of patients diagnosed (prevalence) with Epilepsy by countries
  • Epilepsy drugs: Identify key drugs marketed and prescribed for Epilepsy in the US, including trade name, molecule name, and company
  • Epilepsy drugs sales: Find out the sales value for Epilepsy drugs by countries
  • Epilepsy market valuations: Find out the market size for Epilepsy drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Epilepsy drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Epilepsy drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Epilepsy market
  • Develop in-depth knowledge of competition and markets
  • Analyze Epilepsy drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Epilepsy market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 2
1. Epilepsy Treatment Options

2. Epilepsy Pipeline Insights
2.1. Epilepsy Phase 3 Clinical Trials
2.2. Epilepsy Phase 2 Clinical Trials
2.3. Epilepsy Phase 1 Clinical Trials

3. Epilepsy Epidemiology Analysis by Countries

4. US Epilepsy Market Insights
4.1. Marketed Drugs for Epilepsy in US
4.2. US Epilepsy Market Size & Forecast
4.3. US Epilepsy Drugs Sales & Forecast
4.4. US Epilepsy Market Share Analysis

5. Germany Epilepsy Market Insights
5.1. Marketed Drugs for Epilepsy in Germany
5.2. Germany Epilepsy Market Size & Forecast
5.3. Germany Epilepsy Drugs Sales Forecast
5.4. Germany Epilepsy Market Share Analysis

6. France Epilepsy Market Insights
6.1. Marketed Drugs for Epilepsy in France
6.2. France Epilepsy Market Size & Forecast
6.3. France Epilepsy Product Sales Forecast
6.4. France Epilepsy Market Share Analysis

7. Italy Epilepsy Market Insights
7.1. Marketed Drugs for Epilepsy in Italy
7.2. Italy Epilepsy Market Size & Forecast
7.3. Italy Epilepsy Product Sales Forecast
7.4. Italy Epilepsy Market Share Analysis

8. Spain Epilepsy Market Insights
8.1. Marketed Drugs for Epilepsy in Spain
8.2. Spain Epilepsy Market Size & Forecast
8.3. Spain Epilepsy Product Sales Forecast
8.4. Spain Epilepsy Market Share Analysis

9. UK Epilepsy Market Insights
9.1. Marketed Drugs for Epilepsy in UK
9.2. UK Epilepsy Market Size & Forecast
9.3. UK Epilepsy Product Sales Forecast
9.4. UK Epilepsy Market Share Analysis

10. Europe Epilepsy Market Insights
10.1. Europe Epilepsy Market Size & Forecast
10.2. Europe Epilepsy Product Sales Forecast
10.3. Europe Epilepsy Market Share Analysis

11. Japan Epilepsy Market Insights
11.1. Marketed Drugs for Epilepsy in Japan
11.2. Japan Epilepsy Market Size & Forecast
11.3. Japan Epilepsy Product Sales Forecast
11.4. Japan Epilepsy Market Share Analysis

12. Global Epilepsy Market Insights
12.1. Global Epilepsy Market Size & Forecast
12.2. Global Epilepsy Product Sales Forecast
12.3. Global Epilepsy Market Share Analysis

13. Research Methodology

List of Tables
Table 1: Epilepsy Phase 3 Clinical Trials, Global, 2020
Table 2: Epilepsy Phase 2 Clinical Trials, Global, 2020
Table 3: Epilepsy Phase 1 Clinical Trials, Global, 2020
Table 4: Epilepsy Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Epilepsy in US, 2019
Table 6: US Epilepsy Market Size & Forecast ($mn), 2016 - 2024
Table 7: US Epilepsy Product Sales ($mn), 2016 - 2024
Table 8: US Epilepsy Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Epilepsy in Germany, 2019
Table 10: Germany Epilepsy Market Size & Forecast ($mn), 2016 - 2024
Table 11: Germany Epilepsy Product Sales ($mn), 2016 - 2024
Table 12: Germany Epilepsy Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Epilepsy in France, 2019
Table 14: France Epilepsy Market Size & Forecast ($mn), 2016 - 2024
Table 15: France Epilepsy Product Sales ($mn), 2016 - 2024
Table 16: France Epilepsy Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Epilepsy in Italy, 2019
Table 18: Italy Epilepsy Market Size & Forecast ($mn), 2016 - 2024
Table 19: Italy Epilepsy Product Sales ($mn), 2016 - 2024
Table 20: Italy Epilepsy Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Epilepsy in Spain, 2019
Table 22: Spain Epilepsy Market Size & Forecast ($mn), 2016 - 2024
Table 23: Spain Epilepsy Product Sales ($mn), 2016 - 2024
Table 24: Spain Epilepsy Market Events and Trends, 2016 - 2024
Table 25: Marketed Drugs for Epilepsy in UK, 2019
Table 26: UK Epilepsy Market Size & Forecast ($mn), 2016 - 2024
Table 27: UK Epilepsy Product Sales ($mn), 2016 - 2024
Table 28: UK Epilepsy Market Events and Trends, 2016 - 2024
Table 29: Europe Epilepsy Market Size & Forecast ($mn), 2016 - 2024
Table 30: Europe Epilepsy Product Sales ($mn), 2016 - 2024
Table 31: Marketed Drugs for Epilepsy in Japan, 2019
Table 32: Japan Epilepsy Market Size & Forecast ($mn), 2016 - 2024
Table 33: Japan Epilepsy Product Sales ($mn), 2016 - 2024
Table 34: Japan Epilepsy Market Events and Trends, 2016 - 2024
Table 35: Global Epilepsy Market Size & Forecast ($mn), 2016 - 2024
Table 36: Global Epilepsy Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Epilepsy Pipeline by Phase (%), Global, 2020
Figure 2: Epilepsy Prevalence by Countries, 2016 - 2024
Figure 3: US Epilepsy Market Size ($mn), 2016 - 2024
Figure 4: US Epilepsy Product Sales ($mn), 2016 - 2024
Figure 5: US Epilepsy Market Share by Drugs (%), 2019
Figure 6: US Epilepsy Market - Future Market Share (%), 2024
Figure 7: Germany Epilepsy Market Size ($mn), 2016 - 2024
Figure 8: Germany Epilepsy Product Sales ($mn), 2016 - 2024
Figure 9: Germany Epilepsy Market Share by Drugs (%), 2019
Figure 10: Germany Epilepsy Market - Future Market Share (%), 2024
Figure 11: France Epilepsy Market Size ($mn), 2016 - 2024
Figure 12: France Epilepsy Product Sales ($mn), 2016 - 2024
Figure 13: France Epilepsy Market Share by Drugs (%), 2019
Figure 14: France Epilepsy Market - Future Market Share (%), 2024
Figure 15: Italy Epilepsy Market Size ($mn), 2016 - 2024
Figure 16: Italy Epilepsy Product Sales ($mn), 2016 - 2024
Figure 17: Italy Epilepsy Market Share by Drugs (%), 2019
Figure 18: Italy Epilepsy Market - Future Market Share (%), 2024
Figure 19: Spain Epilepsy Market Size ($mn), 2016 - 2024
Figure 20: Spain Epilepsy Product Sales ($mn), 2016 - 2024
Figure 21: Spain Epilepsy Market Share by Drugs (%), 2019
Figure 22: Spain Epilepsy Market - Future Market Share (%), 2024
Figure 23: UK Epilepsy Market Size ($mn), 2016 - 2024
Figure 24: UK Epilepsy Product Sales ($mn), 2016 - 2024
Figure 25: UK Epilepsy Market Share by Drugs (%), 2019
Figure 26: UK Epilepsy Market - Future Market Share (%), 2024
Figure 27: Europe Epilepsy Market Size ($mn), 2016 - 2024
Figure 28: Europe Epilepsy Product Sales ($mn), 2016 - 2024
Figure 29: Europe Epilepsy Market Share by Drugs (%), 2019
Figure 30: Europe Epilepsy Market - Future Market Share (%), 2024
Figure 31: Japan Epilepsy Market Size ($mn), 2016 - 2024
Figure 32: Japan Epilepsy Product Sales ($mn), 2016 - 2024
Figure 33: Japan Epilepsy Market Share by Drugs (%), 2019
Figure 34: Japan Epilepsy Market - Future Market Share (%), 2024
Figure 35: Global Epilepsy Market Size ($mn), 2016 - 2024
Figure 36: Global Epilepsy Product Sales ($mn), 2016 - 2024
Figure 37: Global Epilepsy Market Share by Drugs (%), 2019
Figure 38: Global Epilepsy Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
Adroll
adroll